HB1712 (2024) Detail

Renewing the committee to study non-pharmacological treatment options for patients with chronic pain.


HB 1712 - VERSION ADOPTED BY BOTH BODIES

 

05/15/2024   1732s

2024 SESSION

24-3164

08/06

 

HOUSE BILL 1712

 

AN ACT renewing the committee to study non-pharmacological treatment options for patients with chronic pain.

 

SPONSORS: Rep. Nagel, Belk. 6; Rep. Merchant, Sull. 6; Rep. Lundgren, Rock. 16; Rep. Calabro, Hills. 45; Sen. Chandley, Dist 11

 

COMMITTEE: Health, Human Services and Elderly Affairs

 

-----------------------------------------------------------------

 

ANALYSIS

 

This bill renews the committee to study non-pharmacological treatment options for patients with chronic pain.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

05/15/2024   1732s 24-3164

08/06

 

STATE OF NEW HAMPSHIRE

 

In the Year of Our Lord Two Thousand Twenty Four

 

AN ACT renewing the committee to study non-pharmacological treatment options for patients with chronic pain.

 

Be it Enacted by the Senate and House of Representatives in General Court convened:

 

1  Findings.  The general court finds that during 2023 meetings, the committee to study non-pharmacological treatment options for patients with chronic pain established that a patient-centric, integrated model of care is a credible and practical foundation upon which to build a pilot program.  The committee recommends continuation of its work for another year to explore how to create an innovative method of payment necessary to support this new model.

2  Committee Established; Non-pharmacological Treatment Options for Chronic Pain.

I.  There is established a committee to study non-pharmacological treatment options to treat patients with chronic pain and the creation of a pilot program that supports and encourages non-pharmacological treatment options.

II  The members of the committee shall consist of:

(a)  Five members of the house of representatives, 2 of whom shall be from the house health, human services, and elderly affairs committee, one from the house commerce committee, and 2 at large, all appointed by the speaker of the house of representatives.

(b)  One member of the senate, appointed by the president of the senate.

III.  Members of the committee shall receive mileage at the legislative rate when attending to the duties of the committee.  The committee’s study shall include, but not be limited to, the following:

(a)  Design of a pilot program with goals that are patient-centric, provider-friendly, that uses existing provider networks, establishes standard reimbursement rates, and maximizes patient self-referrals with no or minimal cost increases.

(b)  Research the creation of such a pilot program with the New Hampshire Medicaid program, the New Hampshire state employee self-funded health insurance program, or with other entities supported with state funds.

(c)  Investigate overall cost of such a program, including eligibility status for National Institutes of Health-National Center for Complementary and Integrative Health supported grants or funding opportunities.

(d)  Research ways to enhance awareness of non-pharmacological treatment options through educational programs for primary care providers to enhance collaboration and integration of care between all providers who collectively assist in treating chronic pain.

(e)  Design a process to collect usable, meaningful data over 3 to 5 years to evaluate meeting the goals of the program design, specifically whether the pilot program helps patients to reduce pain while safely improving functional outcomes and quality of care for patients with chronic pain, increase use of non-pharmacological treatments options, while maintaining affordability by constraining cost or with minimal increases in overall costs to treat chronic pain.

IV.  The committee may solicit input from any person or entity the committee deems relevant to its study.

V.  The members of the committee shall elect a chairperson from among the members.  The first meeting of the committee shall be called by the first-named house member.  The first meeting of the committee shall be held within 45 days of the effective date of this section.  Four members of the committee shall constitute a quorum.

VI.  Notwithstanding RSA 14:49, on or before November 1, 2024, the committee shall submit an interim report including its findings and any recommendations for proposed legislation to the speaker of the house of representatives, the president of the senate, the house clerk, the senate clerk, and the governor.  The committee shall submit a final report of its findings and any recommendations for proposed legislation to the same on or before November 1, 2025.

3  Effective Date. This act shall take effect upon its passage.

Amendments

Date Amendment
May 2, 2024 2024-1732s

Links


Date Body Type
March 6, 2024 House Hearing
March 6, 2024 House Exec Session
March 6, 2024 House Floor Vote
April 24, 2024 Senate Hearing
April 24, 2024 Senate Hearing
May 16, 2024 Senate Floor Vote

Bill Text Revisions

HB1712 Revision: 42522 Date: May 30, 2024, 3:02 p.m.
HB1712 Revision: 42144 Date: May 16, 2024, 1:59 p.m.
HB1712 Revision: 41762 Date: May 2, 2024, 8:29 a.m.
HB1712 Revision: 40902 Date: Feb. 15, 2024, 11:13 a.m.

Docket


May 31, 2024: House Concurs with Senate Amendment 2024-1732s (Rep. W. MacDonald): MA VV 05/30/2024 HJ 15


May 9, 2024: Ought to Pass with Amendment 2024-1732s, MA, VV; OT3rdg; 05/15/2024; SJ 12


May 9, 2024: Committee Amendment # 2024-1732s, AA, VV; 05/15/2024; SJ 12


May 2, 2024: Committee Report: Ought to Pass with Amendment #2024-1732s, 05/16/2024; Vote 5-0; CC; SC 19


April 18, 2024: ==ROOM CHANGE== Hearing: 04/24/2024, Room 103, SH, 09:15 am; SC 16


April 17, 2024: Hearing: 04/24/2024, Room 101, LOB, 09:15 am; SC 17


March 26, 2024: Introduced 03/21/2024 and Referred to Health and Human Services; SJ 8


March 21, 2024: Ought to Pass: MA VV 03/21/2024 HJ 9


March 12, 2024: Committee Report: Ought to Pass 03/06/2024 (Vote 20-0; CC)


Feb. 28, 2024: Executive Session: 03/06/2024 10:00 am LOB 203


Feb. 28, 2024: Public Hearing: 03/06/2024 09:30 am LOB 203


Feb. 15, 2024: Late Drafting and Introduction Approved by House by the Necessary 2/3 MA 02/08/2024 HJ 4 P. 47


Feb. 15, 2024: Introduced (in recess of) 02/08/2024 and referred to Health, Human Services and Elderly Affairs HJ 4 P. 47